Breakdown | |||||
TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
6.04M | 4.73M | 5.50M | 5.01M | 3.60M | 4.76M | Gross Profit |
2.44M | 2.28M | 2.61M | 1.88M | 1.31M | 2.32M | EBIT |
-1.69M | -1.19M | -1.03M | -2.15M | -2.83M | -1.26M | EBITDA |
-851.00K | -363.00K | -271.00K | -937.00K | -1.69M | -579.00K | Net Income Common Stockholders |
-1.71M | -1.32M | -1.12M | -2.19M | -2.80M | -1.29M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
933.00K | 700.00K | 740.00K | 1.14M | 1.99M | 3.11M | Total Assets |
8.89M | 7.75M | 8.40M | 9.73M | 10.76M | 12.75M | Total Debt |
3.31M | 2.81M | 3.05M | 1.94M | 2.11M | 2.24M | Net Debt |
2.61M | 2.10M | 2.31M | 1.25M | 569.00K | -476.00K | Total Liabilities |
4.07M | 4.09M | 4.11M | 4.21M | 3.84M | 3.91M | Stockholders Equity |
4.82M | 3.66M | 4.29M | 5.53M | 6.91M | 8.84M |
Cash Flow | Free Cash Flow | ||||
-168.00K | -486.00K | 56.00K | -1.31M | -2.25M | -4.59M | Operating Cash Flow |
-59.50K | -422.00K | 166.00K | -1.01M | -1.94M | -504.00K | Investing Cash Flow |
-730.00K | -64.00K | -110.00K | -292.00K | -299.00K | -4.09M | Financing Cash Flow |
800.00K | 434.00K | -98.00K | 322.00K | 943.00K | 2.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
58 Neutral | £6.11M | ― | -11.10% | ― | 14.51% | 77.27% | |
55 Neutral | £1.95M | ― | -198.56% | ― | -55.51% | 93.81% | |
50 Neutral | $2.00B | -1.12 | -21.15% | 3.68% | 2.69% | -30.65% | |
£7.44M | ― | -70.02% | ― | ― | ― | ||
43 Neutral | £5.97M | ― | -92.35% | ― | -27.64% | ― | |
£43.17M | 20.55 | 6.20% | ― | ― | ― | ||
50 Neutral | £13.49M | ― | -17.98% | ― | -19.70% | -15.81% |
Hardide plc announced that Dr. Bryan Allcock, a Non-Executive Director, purchased 63,451 ordinary shares of the company at a price of 7.88 pence per share. This transaction increases Dr. Allcock’s stake to 0.1% of the company’s issued share capital. The purchase reflects confidence in the company’s market position and its advanced coating technology, which is crucial for industries requiring durable and efficient component solutions.
Hardide plc announced that its CEO, Matt Hamblin, and Non-Executive Chair, Andrew Magson, have purchased additional ordinary shares in the company. This move signifies a strong vote of confidence in the company’s future prospects and may positively influence stakeholder perceptions, potentially impacting the company’s market position and investor relations.
Hardide PLC reported a significant financial turnaround for the six months ending March 31, 2025, with a 32% increase in revenue and improved gross margins. The company became EBITDA profitable and cash generative, driven by strong demand in the aerospace sector and operational efficiencies. The completion of operational harmonization between its US and UK plants and the introduction of new service offerings are expected to enhance customer service and drive further growth. The company is also engaged in several innovative projects, including applications in carbon capture and green hydrogen production, positioning it well for future growth.
Hardide plc announced that all resolutions at its Annual General Meeting were passed, indicating strong shareholder support. This outcome is expected to positively impact the company’s operations by reinforcing its strategic direction and market positioning in the advanced surface coating technology sector.
Hardide plc, a leader in advanced surface coating technology, reports a promising financial outlook for the first half of 2025, with expected revenue growth of approximately 30% compared to the previous year. This growth is driven by developments in the aerospace sector and a recovery in the oil and gas industry. The company is focused on accelerating revenue growth and optimizing production capacity, with strategic projects in the UK and USA expected to complete by the third quarter. The Board remains confident in meeting full-year performance expectations under new management.